Swati Vijan - Ajooni Biotech Company Officer
AJOONI Stock | 7.42 0.04 0.54% |
Insider
Swati Vijan is Company Officer of Ajooni Biotech Limited
Address | D-118, Industrial Area, Mohali, India, 160055 |
Phone | 91 17 2502 0758 |
Web | https://www.ajoonibiotech.com |
Ajooni Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0139 % which means that it generated a profit of $0.0139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0354 %, meaning that it generated $0.0354 on every $100 dollars invested by stockholders. Ajooni Biotech's management efficiency ratios could be used to measure how well Ajooni Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ajooni Biotech's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 339.4 M, whereas Non Current Assets Total are forecasted to decline to about 80.7 M.Similar Executives
Found 12 records | INSIDER Age | ||
Amur Lakshminarayanan | Tata Communications Limited | 63 | |
Aadesh Goyal | Tata Communications Limited | 61 | |
Luu Tri | Tata Communications Limited | 57 | |
Vipul Jain | Ankit Metal Power | N/A | |
Sumeet Walia | Tata Communications Limited | 50 | |
Vipul Garg | Tata Communications Limited | N/A | |
Andrew Yeong | Tata Communications Limited | N/A | |
Zubin Patel | Tata Communications Limited | N/A | |
Vineeta Barmecha | Ankit Metal Power | N/A | |
Kabir Shakir | Tata Communications Limited | N/A | |
Troy Reynolds | Tata Communications Limited | N/A | |
Subham Bhagat | Ankit Metal Power | 30 |
Management Performance
Return On Equity | 0.0354 | ||||
Return On Asset | 0.0139 |
Ajooni Biotech Leadership Team
Elected by the shareholders, the Ajooni Biotech's board of directors comprises two types of representatives: Ajooni Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ajooni. The board's role is to monitor Ajooni Biotech's management team and ensure that shareholders' interests are well served. Ajooni Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ajooni Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Swati Vijan, Company Officer | ||
Gursimran Singh, CEO Director | ||
Partek Singh, WholeTime Director | ||
Jasjot Singh, MD Chairman |
Ajooni Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ajooni Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0354 | ||||
Return On Asset | 0.0139 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | 0.03 % | ||||
Current Valuation | 754.71 M | ||||
Shares Outstanding | 99.37 M | ||||
Price To Book | 1.73 X | ||||
Price To Sales | 0.91 X | ||||
Revenue | 800.01 M | ||||
Gross Profit | 87.45 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ajooni Stock
Ajooni Biotech financial ratios help investors to determine whether Ajooni Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajooni with respect to the benefits of owning Ajooni Biotech security.